ストックスクリーナーアプリを入手
57.55
2.29%
1.29
アフターアワーズ：
58.19
0.64
+1.11%
前日終値:
$56.26
開ける：
$56.07
24時間の取引高:
1.24M
Relative Volume:
1.80
時価総額：
$3.61B
収益：
$155.82M
当期純損益:
$-40.42M
株価収益率:
-81.06
EPS:
-0.71
ネットキャッシュフロー:
$3.58M
1週間 パフォーマンス:
-12.20%
1か月 パフォーマンス:
-2.72%
6か月 パフォーマンス:
-44.16%
1年 パフォーマンス:
+9.14%
1日の値動き範囲:
$54.98
$59.19
1週間の範囲:
$47.86
$65.44
52週間の値動き範囲:
$47.86
$107.37
Arcellx Inc Stock (ACLX) Company Profile
ACLX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ACLX
Arcellx Inc
|
57.55 | 3.61B | 155.82M | -40.42M | 3.58M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcellx Inc Stock (ACLX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-08 | 開始されました | Redburn Atlantic | Buy |
| 2024-09-03 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-05-31 | 開始されました | Piper Sandler | Overweight |
| 2024-03-07 | 開始されました | Morgan Stanley | Overweight |
| 2024-01-04 | 繰り返されました | Needham | Buy |
| 2023-12-19 | 開始されました | Scotiabank | Sector Outperform |
| 2023-10-30 | 開始されました | TD Cowen | Outperform |
| 2023-10-17 | 開始されました | UBS | Buy |
| 2023-05-18 | 開始されました | Truist | Buy |
| 2023-04-14 | 開始されました | Robert W. Baird | Outperform |
| 2023-03-14 | 開始されました | Stifel | Buy |
| 2023-02-13 | 開始されました | H.C. Wainwright | Buy |
| 2022-12-13 | 再開されました | BofA Securities | Buy |
| 2022-10-31 | 開始されました | Guggenheim | Buy |
| 2022-10-27 | 開始されました | Needham | Buy |
| 2022-07-20 | 開始されました | Canaccord Genuity | Buy |
| 2022-03-01 | 開始されました | BofA Securities | Buy |
| 2022-03-01 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Arcellx Inc (ACLX) 最新ニュース
Arcellx price target lowered to $93 from $133 at Scotiabank - TipRanks
Promising Potential of Arcellx Inc’s Anito-cel Therapy: A Buy Rating Backed by Positive Study Data and Strategic Trial Enhancements - TipRanks
Arcellx’s Promising Trial Results and Strategic Partnerships Justify Buy Rating with $121 Target - TipRanks
Arcellx Inc. Receives Buy Rating: Strong Financial Outlook and Promising Data Catalysts - TipRanks
Promising Potential of Arcellx Inc’s Anito-cel Program Drives Buy Rating - TipRanks
Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
ARCELLX Earnings Results: $ACLX Reports Quarterly Earnings - Nasdaq
Earnings Flash (ACLX) ARCELLX INC. Reports Q1 Revenue $8.1M, vs. FactSet Est of $19.5M - marketscreener.com
Arcellx Provides First Quarter 2025 Financial Results and Business Highlights - Business Wire
Before Buying Arcellx Inc (NASDAQ: ACLX) Stock, Read This First - Stocksregister
Arcellx, Inc. (NASDAQ:ACLX) Stake Reduced by Envestnet Asset Management Inc. - Defense World
Investor’s Toolkit: Key Ratios for Assessing Arcellx Inc (ACLX)’s Performance - DWinneX
Dimensional Fund Advisors LP Buys 186,013 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx (ACLX) to Release Quarterly Earnings on Thursday - Defense World
Arcellx Enters Oversold Territory (ACLX) - Nasdaq
Arcellx, Inc. (NASDAQ:ACLX) Shares Acquired by Invesco Ltd. - Defense World
(ACLX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Wells Fargo & Company MN Has $2.04 Million Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
William Blair Sticks to Its Buy Rating for Arcellx Inc (ACLX) - The Globe and Mail
Arcellx, Inc. (ACLX): Among Takeover Rumors Hedge Funds Are Buying - EMEA Tribune
Alliancebernstein L.P. Sells 6,181 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
(ACLX) Proactive Strategies - news.stocktradersdaily.com
Wellington Management Group LLP Trims Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Insider Selling: Arcellx, Inc. (NASDAQ:ACLX) Director Sells 1,500 Shares of Stock - MarketBeat
Arcellx (ACLX): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential - Insider Monkey
Arcellx (NASDAQ:ACLX) Trading Down 6.8% on Insider Selling - Defense World
Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset - MSN
Arcellx director Kavita Patel sells shares worth $86,250 By Investing.com - Investing.com Australia
Sei Investments Co. Purchases 4,827 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx director Kavita Patel sells shares worth $86,250 - Investing.com
29,446 Shares in Arcellx, Inc. (NASDAQ:ACLX) Purchased by American Century Companies Inc. - Defense World
Vanguard Group Inc. Grows Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx, Inc. (NASDAQ:ACLX) Stake Lessened by Corebridge Financial Inc. - Defense World
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday - Benzinga
What You Didn’t Know About Arcellx Inc (NASDAQ: ACLX) This Week - stocksregister.com
Arcellx Inc (ACLX) rating initates by Redburn Atlantic - knoxdaily.com
Teacher Retirement System of Texas Purchases 1,505 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
In 2025, Will Arcellx Inc (NASDAQ: ACLX) Be Bullish Or Bearish? - Stocks Register
How To Trade (ACLX) - news.stocktradersdaily.com
Swiss National Bank Buys 500 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Raymond James Financial Inc. Acquires New Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors - BioSpace
Arcellx Inc Announces Board Changes for Strategic Growth - TipRanks
Arcellx names new board members, gears up for 2026 launch By Investing.com - Investing.com Australia
Arcellx Appoints Andrew Galligan And Kristin Myers To Its Board Of Directors - MarketScreener
Arcellx names new board members, gears up for 2026 launch - Investing.com
Arcellx director Kavita Patel sells $107,460 in common stock By Investing.com - Investing.com Australia
Arcellx Inc (ACLX) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):